147 related articles for article (PubMed ID: 28879109)
1. Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion.
Nkohkwo A; Agbor G; Asongalem E; Tagny C; Asonganyi T
Afr J Lab Med; 2016; 5(1):363. PubMed ID: 28879109
[TBL] [Abstract][Full Text] [Related]
2. The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.
Kasirye R; Hume HA; Bloch EM; Lubega I; Kyeyune D; Shrestha R; Ddungu H; Musana HW; Dhabangi A; Ouma J; Eroju P; de Lange T; Tartakovsky M; White JL; Kakura C; Fowler MG; Musoke P; Nolan M; Grabowski MK; Moulton LH; Stramer SL; Whitby D; Zimmerman PA; Wabwire D; Kajja I; McCullough J; Goodrich R; Quinn TC; Cortes R; Ness PM; Tobian AAR
Trials; 2022 Apr; 23(1):257. PubMed ID: 35379302
[TBL] [Abstract][Full Text] [Related]
3. Blood transfusion safety in sub-Saharan Africa: A literature review of changes and challenges in the 21st century.
Weimer A; Tagny CT; Tapko JB; Gouws C; Tobian AAR; Ness PM; Bloch EM
Transfusion; 2019 Jan; 59(1):412-427. PubMed ID: 30615810
[TBL] [Abstract][Full Text] [Related]
4. Pathogen reduction of whole blood: utility and feasibility.
Allain JP; Goodrich R
Transfus Med; 2017 Oct; 27 Suppl 5():320-326. PubMed ID: 28875531
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology.
Salunkhe V; De Cuyper IM; Papadopoulos P; van der Meer PF; Daal BB; Villa-Fajardo M; de Korte D; van den Berg TK; Gutiérrez L
Platelets; 2019; 30(3):368-379. PubMed ID: 29553857
[TBL] [Abstract][Full Text] [Related]
6. Highlights of PBTI Coimbra Conference on PRT of Plasma & Current Opinions on Pathogen Reduction Treatment of Blood Components.
de Sousa G; Seghatchian J
Transfus Apher Sci; 2015 Apr; 52(2):228-32. PubMed ID: 25770045
[TBL] [Abstract][Full Text] [Related]
7. HIV and blood transfusion in sub-Saharan Africa.
Fleming AF
Transfus Sci; 1997 Jun; 18(2):167-79. PubMed ID: 10174681
[TBL] [Abstract][Full Text] [Related]
8. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
[TBL] [Abstract][Full Text] [Related]
9. Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice.
Caudrillier A; Mallavia B; Rouse L; Marschner S; Looney MR
PLoS One; 2015; 10(7):e0133022. PubMed ID: 26176623
[TBL] [Abstract][Full Text] [Related]
10. Mapping mHealth (mobile health) and mobile penetrations in sub-Saharan Africa for strategic regional collaboration in mHealth scale-up: an application of exploratory spatial data analysis.
Lee S; Cho YM; Kim SY
Global Health; 2017 Aug; 13(1):63. PubMed ID: 28830540
[TBL] [Abstract][Full Text] [Related]
11. The risk of transfusion-transmitted infections in sub-Saharan Africa.
Jayaraman S; Chalabi Z; Perel P; Guerriero C; Roberts I
Transfusion; 2010 Feb; 50(2):433-42. PubMed ID: 19843290
[TBL] [Abstract][Full Text] [Related]
12. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
13. Depression among epileptic patients and its association with drug therapy in sub-Saharan Africa: A systematic review and meta-analysis.
Dessie G; Mulugeta H; Leshargie CT; Wagnew F; Burrowes S
PLoS One; 2019; 14(3):e0202613. PubMed ID: 30870423
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion in sub-Saharan Africa: understanding the missing gap and responding to present and future challenges.
Barro L; Drew VJ; Poda GG; Tagny CT; El-Ekiaby M; Owusu-Ofori S; Burnouf T
Vox Sang; 2018 Nov; 113(8):726-736. PubMed ID: 30221365
[TBL] [Abstract][Full Text] [Related]
15. Health economics of blood transfusion safety--focus on sub-Saharan Africa.
van Hulst M; Smit Sibinga CT; Postma MJ
Biologicals; 2010 Jan; 38(1):53-8. PubMed ID: 20022523
[TBL] [Abstract][Full Text] [Related]
16. Mirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice.
Mallavia B; Kwaan N; Marschner S; Yonemura S; Looney MR
PLoS One; 2017; 12(6):e0178725. PubMed ID: 28570672
[TBL] [Abstract][Full Text] [Related]
17. Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial.
Allain JP; Owusu-Ofori AK; Assennato SM; Marschner S; Goodrich RP; Owusu-Ofori S
Lancet; 2016 Apr; 387(10029):1753-61. PubMed ID: 27116282
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the Mirasol pathogen reduction technology system against severe fever with thrombocytopenia syndrome virus (SFTSV).
Shinohara N; Matsumoto C; Chatani M; Uchida S; Yoshikawa T; Shimojima M; Satake M; Tadokoro K
Vox Sang; 2015 Nov; 109(4):417-9. PubMed ID: 26031768
[TBL] [Abstract][Full Text] [Related]
19. Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.
Cicchetti A; Coretti S; Sacco F; Rebulla P; Fiore A; Rumi F; Di Bidino R; Urbina LI; Refolo P; Sacchini D; Spagnolo AG; Midolo E; Marano G; Farina B; Pati I; Veropalumbo E; Pupella S; Liumbruno GM
Blood Transfus; 2018 Nov; 16(6):483-489. PubMed ID: 30201081
[TBL] [Abstract][Full Text] [Related]
20. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
